Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial
American Journal of PsychiatryPublished 1 January 1997
Robert Berman, Adam Darnell, Hannah L. Miller, Amit Anand, Dennis S. Charney
Citations173
SJR quartileQ1
SJR score5.27
SNIP3.68
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The efficacy of pindolol in hastening clinical response in patients treated with fluoxetine is not supported, and the average time to remission and the rates of attrition, overall response, and side effects were similar in the two groups.
Abstract
These findings do not support the efficacy of pindolol in hastening clinical response in patients treated with fluoxetine.
Keywords
PsychologyMedicine
Archives of General PsychiatryAn Inventory for Measuring Depression
38,163 Citations1961Aaron T. Beck
The difficulties inherent in obtaining consistent and adequate diagnoses for the purposes of research and therapy have been pointed out and a wide variety of psychiatric rating scales have been developed.
Trends in Pharmacological SciencesCurrent advances and trends in the treatment of depression
1,113 Citations1994Pierre Blier, Claude de Montigny
A better understanding of the neurobiological basis for the delayed onset of action of antidepressant treatments has led to the elaboration of strategies that could accelerate the antidepressant response.
Archives of General PsychiatryPindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors
510 Citations1994Francesc Artigas
These findings suggest that the antidepressant effects of uptake and MAO inhibitors emerge when serotonergic activity increases, and extracellular 5-HT concentration is dramatically augmented by the same doses in the vicinity of cell bodies ofserotonergic neurons, in the midbrain raphe nuclei.
ScienceTricyclic Antidepressants: Long-Term Treatment Increases Responsivity of Rat Forebrain Neurons to Serotonin
476 Citations1978Claude de Montigny, George K. Aghajanian
The enhanced response to serotonin induced by the clinically active tricyclic drugs took 1 to 2 weeks to develop, a time course which correlates with the delayed onset of therapeutic effects in humans.
Journal of Clinical PsychopharmacologyModifications of the Serotonin System by Antidepressant Treatments
404 Citations1987Pierre Blier, Claude de Montigny +1 more
Results of electrophysiological single-cell recording studies suggest that most, if not all, types of antidepressant treatments increase 5-hydroxytryptamine (5-HT) neurotransmission.
Journal of Clinical PsychopharmacologyEffectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression
321 Citations1995Pierre Blier, Richard Bergeron
The results of these studies indicate that pindolol is safe when used in combination with an SSRI or moclobemide and should be tested under double-blind conditions to establish its efficacy.
Archives of General PsychiatryCarbon Dioxide—Induced Anxiety
264 Citations1988Scott W. Woods
The physiologic and biochemical measurements obtained did not elucidate the mechanisms underlying CO2-induced anxiety or the greater anxiogenic effects of CO2 seen in patients with panic disorders.
PubMedPresynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
250 Citations1991Yves Chaput, Claude de Montigny +1 more
The present data confirm and extend those of previous electrophysiologic studies showing that an enhanced 5-HT synaptic transmission is a common end result of long-term administration of various types of antidepressant treatments and suggest that the mechanisms underlying this enhanced synaptic transmission differ according to the type of treatment administered.
Journal of NeurochemistrySerotonin 5‐HT<sub>1A</sub> Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis Study
236 Citations1993Stephan Hjorth
Evidence is provided that5‐HT, in particular 5‐HT1A, autoreceptor‐mediated negative feedback mechanisms are pivotal in determining the nerve terminal 5‐ HT output level after 5‐ht reuptake inhibition, and this has important implications for the interplay between different processes controlling 5-HT transmission in vivo.
Journal of Receptor Research5-HT Receptors: Subtypes and Second Messengers
199 Citations1991Daniël Hoyer, Philippe Schoeffter
Three main families of 5-HT receptors, of which subtypes have been described, are now accepted, and heterogeneity is further substantiated by the cloning of the cDNA's of three different 5- HT receptors.
European NeuropsychopharmacologyTime course of improvement under antidepressant treatment: A survival-analytical approach
189 Citations1993Hans H. Stassen, A. Delini‐Stula +1 more
The most interesting and unexpected finding of the analysis was that the time course of improvement among responders was independent of the treatment modality, and thus identical in all three groups.
European Journal of PharmacologySubtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat
141 Citations1985Mark D. Tricklebank, Christian Forler +2 more
Results are consistent with the hypothesis that forepaw treading induced by 5-MeODMT arises by activation of the putative 5-HT1A receptor, and antagonism of the flat body posture by pindolol could be demonstrated only in non-reserpinised rats and the mechanism of induction of this behaviour remains to be established.
Acta Psychiatrica ScandinavicaA double‐blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients
111 Citations1993J. De Wilde, R. Spiers +4 more
ParoxETine and fluoxetine showed comparable efficacy at the end of the 6‐week treatment period, but a statistically significant difference in the number of responders at week 3 in favour of paroxetines was observed, which could suggest an earlier onset of action with paroxettine.
Archives of General PsychiatryReliability and Validity of the Symptoms of Major Depressive Illness
104 Citations1986Carolyn M. Mazure
Results indicated that most signs and symptoms of major depression and melancholia can be reliably rated by clinicians during a semistructured interview.
Journal of Clinical PsychopharmacologyA Double-Blind Study of Paroxetine Compared With Fluoxetine in Geriatric Patients With Major Depression
96 Citations1993WILFRIED SCH NE, MONIKA LUDWIG
During treatment, patients in the paroxetine group were characterized by greater improvement in cognitive function than were those in the fluoxettine group, and this result was statistically significant at week 3 for both scales.
Journal of Pharmacology and Experimental TherapeuticsIn vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
88 Citations1993Stephan Hjorth, Trevor Sharp
The data indicate that (-)penbutolol possesses 5-HT1A and 5-ht1B autoreceptor antagonist properties, and may be a useful tool in studies of central 5- HT receptor-mediated function.
European Journal of Clinical PharmacologyPharmacology of the hypothermic response to 5-HT1A receptor activation in humans
87 Citations1990Klaus‐Peter Lesch, Bettina Poten +2 more
The findings indicate that IPS-induced hypothermia specifically involves activation of (presynaptic) 5-HT1A receptors and may provide a convenient in vivo paradigma to assess the function of the presynaptic 5- HT receptor in affective disorders and its involvement in the effects of psychotropic drugs.
Journal of Clinical PsychopharmacologyA Double-Blind, Randomized, Fluoxetine-Controlled, Multicenter Study of Paroxetine in the Treatment of Depression
71 Citations1993Jean Tignol
A marked antidepressant response and good tolerability were seen with both drugs, which further support the usefulness of paroxetine in the treatment of depressive illness.
Life SciencesThe role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro
24 Citations1991Serge Ferrari, T. Leemann +1 more